日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Innovation

Hong Kong medicine scholars develop innovative targeted delivery system for treating bone tumor

Xinhua | Updated: 2017-11-09 17:19

HONG KONG - China's Hong Kong Baptist University (HKBU) announced Thursday that its medicine scholars have succeeded in developing a novel targeted delivery system for CRISPR/Cas9 to achieve therapeutic genome editing of VEGFA in osteosarcoma (OS).

Their research paper, entitled "Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalised lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma", was recently published in the internationally renowned academic journal Biomaterials.

CRISPR/Cas9 is a budding genome editing technology which holds tremendous promise for cancer treatment. However, a major bottleneck for achieving the therapeutic potential of CRISPR/Cas9 is the lack of an in vivo targeted delivery system.

The HKBU team has achieved a breakthrough in the search for an answer to the crux of the above mentioned problem and developed an aptamer-functionalised delivery system for CRISPR/Cas9 with the treatment of OS as a research target.

The research team is led by Professor Lyu Aiping, dean of the School of Chinese Medicine (SCM) of HKBU, and Professor Zhang Ge, Director of Technology Development Division and Associate Director of Teaching and Research Division of SCM.

"OS, a very common primary malignant bone tumor in children and adolescents, is mainly treated by surgery and chemotherapy, but the five-year post-surgery survival rate is a mere 5 percent to 20 percent," Zhang said, "Aptamers which are single-stranded oligonucleotides and could specifically recognize target cells have been widely used for in vivo targeted delivery of therapeutics. VEGFA has been reported to be a novel therapeutic target for OS."

Lyu said,"The tumor-specific aptamers, when conjugated with PPC polymers encapsulating CRISPR/Cas9, may facilitate therapeutic genome editing in tumors."

In the experiments using a mouse model, the aptamer facilitated selective distribution of CRISPR/Cas9 in both orthotopic OS and lung metastasis, leading to effective in vivo VEGFA genome editing, inhibited orthotopic OS malignancy and lung metastasis, as well as reduced angiogenesis and bone lesion with no detectable toxicity. The research facilitated clinical application of CRISPR/Cas9 in tumor treatment.

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 97视频久久久 | 天天骑夜夜操 | 亚洲99| 亚洲国产精品久久网午夜 | 久久精品伊人 | 亚洲欧美韩国日产综合在线 | 午夜视频国语 | 亚洲国产午夜电影在线入口 | 中文字幕视频在线 | 黄色片的网站 | 天天干天天操天天爽 | 亚洲国产高清高潮精品美女 | 国产二区视频 | 青娱乐免费视频 | 日本aaa级片 | 激情综合五月亚洲婷婷 | 亚州毛色毛片免费观看 | 久久影院在线观看 | 中文字幕在线播放 | 亚洲精品乱码久久久久久蜜桃91 | 美国免费黄色片 | 亚洲午夜电影 | 欧美在线你懂的 | 成人v| 久久中文字幕免费 | 伊人国产精品 | 国产精品免费看久久久 | 91在线观看视频 | 国产午夜免费一区二区三区 | 奇米影音第四色 | 亚洲毛片在线观看 | 免费一级毛片在线播放视频 | 国色天香综合网 | 看免费一级毛片 | 欧美大黄| 精品国产一区二区亚洲人成毛片 | 性大毛片视频 | 丰满岳妇乱一区二区三区 | 国产在线中文字幕 | 毛片99 | 日韩av中文|